• Sullivan & Cromwell, Haynes & Boone: Business of Law
  • Lilly Stops Trial of Experimental Alzheimer’s Drug
  • AbbVie Says It Can Be First With New Hepatitis C Drugs
  • Gene Patents Limited by Court in Mixed Ruling for Myriad
  • Pfizer’s Two New Top Pills Selling Slower Than Expected
  • European Stocks Little Changed as U.S. Data Beat Forecast
  • Flu Season Doctor Visits Reached Record at Early Peak
  • Medical-Device Makers Urged by FDA to Boost Cybersecurity
  • Teva CFO Discusses Growth Outlook, Acquisitions
  • Serb Galenika Says It Secures Certificate for Drug Sales in EU
  • Elan Drops as Royal Pharma Says Takeover May Fail
  • Royalty Pharma Says Elan Offer May Lapse Over Buyback
  • Bionor Pharma Surges After HIV Drug Study Progress: Oslo Mover
  • Wockhardt to Lose $17 Million in Sales as India Bans Painkiller
  • SAP, Pfizer-Teva, FIFA, Agilent: Intellectual Property
« Previous 1 2 3 4 5 Next »